What is the maximum daily dose of Geodon (ziprasidone) for acute agitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Daily Dose of Geodon (Ziprasidone) for Acute Agitation

For acute agitation, the maximum daily dose of intramuscular ziprasidone is 40 mg per day 1.

Dosing Algorithm for Acute Agitation

The FDA-approved dosing regimen for IM ziprasidone in acute agitation is structured as follows 1:

  • Initial dose: 10 mg to 20 mg IM
  • Subsequent dosing:
    • 10 mg doses may be repeated every 2 hours as needed
    • 20 mg doses may be repeated every 4 hours as needed
  • Maximum daily dose: 40 mg per day
  • Maximum duration: IM administration beyond 3 consecutive days has not been studied

Key Clinical Considerations

Do not co-administer IM and oral ziprasidone. The FDA label explicitly states there is no safety data for combining IM ziprasidone with oral ziprasidone in the same patient, and this practice is not recommended 1.

Transition to oral therapy promptly. Once the acute agitation is controlled, switch to oral ziprasidone capsules as soon as clinically appropriate 1.

Evidence Supporting This Dosing

The 40 mg/day maximum is supported by multiple clinical trials demonstrating efficacy and safety 2. Class II studies showed that ziprasidone IM 20 mg effectively reduces acute agitation symptoms, with the 20 mg dose demonstrating superior efficacy compared to 10 mg, though both are significantly better than 2 mg 2.

Notably, ziprasidone showed minimal extrapyramidal symptoms (dystonia, akathisia, hypertonia) compared to haloperidol when dosed every 4-6 hours as needed 2.

Important Safety Warnings

  • QT prolongation risk: Avoid in patients with known QT prolongation, recent MI, uncompensated heart failure, or concurrent use of other QT-prolonging drugs 1
  • Elderly patients: While one small study in elderly patients (mean age 71 years) used the same 40 mg/day maximum with acceptable safety 3, a 2025 geriatric guideline suggests ziprasidone performed favorably but notes limited data in this population 4
  • Respiratory depression: In comparative studies, ziprasidone had higher rates of respiratory depression (36-39%) compared to droperidol (12%), though lower than lorazepam (48%) 5

Practical Dosing Strategy

Start with 20 mg IM for most acutely agitated patients, as this dose demonstrates rapid onset (significant improvement within 2 hours) and robust efficacy 6. Reserve the 10 mg dose for elderly patients, those with cardiovascular risk factors, or when a more cautious approach is warranted. You can give a second 20 mg dose after 4 hours if needed, but do not exceed 40 mg total in 24 hours.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.